Latest Asx News

Orthocell has secured Health Canada approval for its nerve repair product Remplir™, adding the US$75 million Canadian market and expanding its total addressable market to US$1.8 billion. The company plans to appoint local distributors and expects first sales in H2 2025.

Northern Minerals has made significant progress on its Browns Range Heavy Rare Earths Project, advancing its feasibility study and exploration while raising $41.5 million, positioning itself as a strategic alternative amid growing geopolitical supply risks.

Jade Gas Holdings has successfully drilled two production wells at Mongolia’s Red Lake gas field, confirming significant coal bed methane potential and preparing for imminent production. The company is advancing commercialisation talks with CNG manufacturers to capitalise on early gas flows.

AnteoTech Ltd reports progress in advanced battery and life sciences technologies alongside a strategic review and leadership changes amid challenging EV market conditions.

Actinogen Medical advances its XanaMIA phase 2b/3 Alzheimer’s trial with faster patient enrolment and expands clinical sites, while achieving a pivotal FDA meeting outcome for its depression program. The company maintains a strong cash position, supporting ongoing development and commercialization efforts.

Percheron Therapeutics has discontinued its ATL1103 program and curtailed investment in ATL1102 following underwhelming trial results, while advancing talks to in-license new rare disease therapies and extending its cash runway into FY2027.

Syntara Limited reports significant clinical progress with its lead myelofibrosis drug SNT-5505 and launches a new trial for its next-generation anti-fibrotic skin treatment, supported by a solid $18 million cash reserve.

Waratah Minerals has reported significant drilling results that extend shallow epithermal gold mineralisation along the 2km Spur Gold Corridor in New South Wales, alongside a full renewal of its key exploration licence through 2031.

AustChina Holdings has completed the acquisition of Penwortham Exploration, gaining full control of promising gold-antimony and base metals projects in Tasmania, and has commenced exploration activities in a prolific mining region.

Northern Minerals Limited reported a $5.8 million cash outflow from operations in Q1 2025 but bolstered its balance sheet with a $42.5 million equity raise, ending the quarter with nearly $30 million in cash.

Powerhouse Ventures Limited reports a robust start to 2025, highlighted by strong fund performance, a successful capital raise, and strategic business expansion despite market volatility.

Waratah Minerals Limited disclosed a quarterly cash outflow of AUD 1.757 million driven by exploration and staff costs, ending March 2025 with AUD 2.436 million in cash. The company plans a capital raise to sustain ongoing drilling at its Spur Project.